Potential therapeutic applications of exosomes in different autoimmune diseases
- PMID: 31228581
- DOI: 10.1016/j.clim.2019.06.006
Potential therapeutic applications of exosomes in different autoimmune diseases
Abstract
Autoimmune diseases are caused by self-immune responses to autoantigens, which damage body tissues and severely affect the patient's quality of life. Therapeutic drugs are associated with adverse side effects and their beneficial effects are limited to specific populations. Evidence indicates that exosomes which are small vesicles secreted by most cell types and body fluids, and may play roles in both immune stimulation and tolerance since they are involved in many processes such as immune signaling, inflammation and angiogenesis. Exosomes have also emerged as promising tools for therapeutic delivery, given their intrinsic features such as stability, biocompatibility and a capacity for stealth. In this review, we summarize existing literature regarding the production, efficacy, action mechanism, and potential therapeutic uses of exosomes in the contexts of autoimmune diseases such as type 1 diabetes mellitus, multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, and Sjogren's syndrome.
Keywords: Exosomes; Multiple sclerosis; Potential therapeutic applications; Rheumatoid arthritis; Sjogren’s syndrome; Systemic lupus erythematosus; Type 1 diabetes mellitus.
Copyright © 2019. Published by Elsevier Inc.
Similar articles
-
The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases.J Neuroimmunol. 2021 Sep 15;358:577640. doi: 10.1016/j.jneuroim.2021.577640. Epub 2021 Jun 24. J Neuroimmunol. 2021. PMID: 34224949 Review.
-
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges.Autoimmun Rev. 2023 Mar;22(3):103260. doi: 10.1016/j.autrev.2022.103260. Epub 2022 Dec 21. Autoimmun Rev. 2023. PMID: 36565798 Review.
-
Autoimmune diseases in China.Adv Immunol. 2019;144:173-216. doi: 10.1016/bs.ai.2019.09.002. Epub 2019 Oct 18. Adv Immunol. 2019. PMID: 31699217
-
Exosomes in Systemic Autoimmune Diseases: Recent Advances in Diagnostic Biomarkers and Therapeutic Applications.Int J Nanomedicine. 2025 Apr 21;20:5137-5160. doi: 10.2147/IJN.S506221. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40292402 Free PMC article. Review.
-
Recent Advances in the Use of Exosomes in Sjögren's Syndrome.Front Immunol. 2020 Aug 6;11:1509. doi: 10.3389/fimmu.2020.01509. eCollection 2020. Front Immunol. 2020. PMID: 32903777 Free PMC article. Review.
Cited by
-
Molecular characteristics and functional differences of anti-PM/Scl autoantibodies and two other distinct and unique supramolecular structures known as "EXOSOMES".Autoimmun Rev. 2020 Oct;19(10):102644. doi: 10.1016/j.autrev.2020.102644. Epub 2020 Aug 12. Autoimmun Rev. 2020. PMID: 32801042 Free PMC article. Review.
-
Anthocyanins as Immunomodulatory Dietary Supplements: A Nutraceutical Perspective and Micro-/Nano-Strategies for Enhanced Bioavailability.Nutrients. 2023 Sep 26;15(19):4152. doi: 10.3390/nu15194152. Nutrients. 2023. PMID: 37836436 Free PMC article. Review.
-
Increased levels of villus-derived exosomal miR-29a-3p in normal pregnancy than uRPL patients suppresses decidual NK cell production of interferon-γ and exerts a therapeutic effect in abortion-prone mice.Cell Commun Signal. 2024 Apr 16;22(1):230. doi: 10.1186/s12964-024-01610-0. Cell Commun Signal. 2024. PMID: 38627796 Free PMC article.
-
Recent advances in surface modification of micro- and nano-scale biomaterials with biological membranes and biomolecules.Front Bioeng Biotechnol. 2022 Oct 12;10:972790. doi: 10.3389/fbioe.2022.972790. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36312538 Free PMC article. Review.
-
Emerging Roles of Exosomes in T1DM.Front Immunol. 2020 Nov 26;11:593348. doi: 10.3389/fimmu.2020.593348. eCollection 2020. Front Immunol. 2020. PMID: 33324409 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical